Xcout Intel
Immitra Bio competitors & alternatives
The 12 closest competitors and alternatives to Immitra Bio among drug discovery companies — ranked by similarity to what Immitra Bio actually does, not by market-cap band.
Subscribe to see Immitra Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Immitra Bio
Immitra Bio GmbH is a biotechnology startup and ETH Zürich spin-off developing a scalable in-vivo genetic medicine platform to treat rare genetic diseases. Headquartered in Schlieren, Switzerland, the company secured early-stage venture funding to advance its gene-editing therapies.
Immitra Bio at a glance
Immitra Bio is a drug discovery company headquartered in Switzerland. Its most recent funding round, Pre-Seed, raised $3M in July 2026. Xcout tracks 2 named people at Immitra Bio, including Jan Nelis (Co-founder and Chief Executive Officer).
Immitra Bio leadership
- Jan NelisCo-founder and Chief Executive Officer
- Amir TaheriCo-founder and Chief Scientific Officer
Immitra Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $3M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Immitra Bio competitors
Ranked by semantic similarity — how close each company is to Immitra Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Similar drug discovery company
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Similar drug discovery company
Eurus Therapeutics is a biotechnology startup headquartered in Fujisawa, Kanagawa Prefecture, Japan. Founded in 2021, the company is building an advanced drug-discovery platform based on a novel genome-editing technology called Eurus Editor.
Biopharma
Scout Bio, Inc. is a veterinary biotechnology company specializing in animal health and advanced gene therapy treatments currently being evaluated in clinical trials.
Biopharma
Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.
Similar drug discovery company
VectorY Therapeutics is a fully integrated gene therapy company founded in August 2020 and based in Amsterdam, Netherlands. The company is focused on developing novel gene therapies, including clinical trials for conditions like amyotrophic lateral sclerosis (ALS).
Similar drug discovery company
Promise Bio is a biotechnology research startup transforming immune-mediated disease treatment with advanced precision therapies. Headquartered in Tel Aviv, Israel, the company emerged from stealth following a seed investment.
Similar drug discovery company
Coultreon Biopharma is a clinical-stage biotechnology company headquartered in Leuven, Belgium, focused on developing next-generation precision medicines for immunology and autoimmune diseases. Backed by substantial venture funding, the company advances innovative therapies.
Similar drug discovery company
LUCA Science is a pre-clinical stage biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs. The company utilizes a proprietary method to isolate functional mitochondria, combining it with advanced drug delivery and formulation technology to create storable biopharmaceutical agents.
Similar drug discovery company
Mighty Therapeutics, formerly known as Stealth BioTherapeutics, focuses on mitochondrial medicine. The company targets mitochondrial dysfunction associated with rare genetic mitochondrial diseases and common diseases of aging through targeted scientific research and treatment development.
Similar drug discovery company
Vivacta Biotechnology is a biopharmaceutical company headquartered in Shanghai, China, specializing in innovative biotechnology research. The company is focused on developing in vivo CAR-T therapies utilizing a targeted delivery system.
Similar drug discovery company
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Immitra Bio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Immitra Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →